Board of Directors

Antonio Boniolo

Graduated in organic chemistry at University of Padua, in 1974, he specializes in bioassays, solid phase biochemistry and diagnostic immunoassay.

He started developing his 30 years industrial career at Sorin Biomedica Diagnostic Division as Research Director first, then managing it as Corporate Vice President up to spinning it off from Sorin Biomedica as Sorin Diagnostics Srl.

After having sold that Company in 1997 to American Standard Companies (Piscataway, N.J., USA), he continued to serve the successor Company Diasorin S.r.l. as CEO and Business Leader of American Standard Medical System Group.

From 2000 to 2006 takes part of the MBO of the Company from American Standard and leads business restructuring towards assay automation and listing DiaSorin Spa at Italian Stock Exchange in 2007. 

After having served DiaSorin S.p.a. as Deputy Chairman of the Board until 2011, in 2014 Antonio decided to team up with Lanfranco Callegaro in founding Jointherapeutics S.r.l., a start-up Company aimed at developing new medical devices for intra-articular diseases based on innovative polysaccharides.

He presently serves Jointherapeutics S.r.l. as Board member and GlycoCore Pharma S.r.l. as Chairman of the Board.

Lanfranco Callegaro

Lanfranco Callegaro has an experience of over 30 years in the operational and business aspects in the pharmaceutical industry.

He has experience in Mergers and Acquisition, booting start ups and R&D focused on the application of technologies in Regenerative Medicine.

He is co-founder and Chairman of Jointherapeutics Srl, a start up company focused on developing innovative products in osteoarticular pathologies.

He is co-founder and member of GlycoCore Pharma Srl’s Board of Directors.

Andrea Senaldi

Andrea Senaldi is a seasoned executive with 20 years experience in the Healthcare industry. Between 2004 and 2011 he was SVP and CFO at DiaSorin an outperforming company in IVD.

Prior to that, he has covered several executive positions in the FMCG industry. More recently, he gathered additional experience with early stage Medtech companies, as Founder and Managing Partner at Valuemaze, an advisor to SMEs on strategy definition/deployment and M&A execution.

In 2019 and 2020, he was Chief Executive Officer at Diadem, an IVD company committed to the development of a test which enables prediction, monitoring, diagnosis and successful drug development for Alzheimer’s Disease.

Andrea holds a Degree in economics and finance.

Luca Melindo

Financial executive with over 20 years of investment and business development experience in mid-market private equity deals in all industries, with a more recent focus on the healthcare sector.

Since 2019 non-executive director of DiaSorin S.p.A., global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments.

Currently Executive Chairman of Sfera Agricola, an innovative hydroponic tomato farming venture with a 12 ha plant in Tuscany and Executive Director of CV Lab, an incubator fully focused on cardiovascular innovation.

Graduated in 1993 summa cum laude in Business and Economics at the University of Torino

Enrico Palandri

Enrico is a co-founder of Eulero Capital Spa.  

Before Eulero, he spent 5 years running Secofind, a multi-family office.  Prior to joining Secofind, he spent 20 years, in IGI a private equity firm, as a partner.  Enrico started his professional career with Arca Merchant, an Italian merchant bank in 1988.

Enrico graduated in Economics and Commerce from Bocconi University.